Biologics manufacturing has been expanding as drugmakers develop more and more cell-based drugs with special capabilities. Boehringer Ingelheim is jumping on…

Drug development specialist Aptuit says it plans to invest $16 million in upgrades and new equipment for its facilities in the U.K. and Italy as well as add 90…

Synerlab, a French pharmaceutical manufacturer, has purchased Spain-based contract development and manufacturing company Alcala Farma for an undisclosed amount.

For several months, Sanofi's new CEO Olivier Brandicourt has indicated that one part of his turnaround plan for the French drugmaker would involve…

AstraZeneca has laid out a host of new manufacturing projects in recent months, including new biologics plants in Europe and the U.S. But while those projects…

Portugal's Hovione is in expansion mode. After saying last month that it would add to its plant in New Jersey, the contract manufacturer now says it…

A couple of years ago, U.S.-based Regeneron said it would turn a former Dell computer plant in Ireland into its production operation outside of the U.S. But…

GlaxoSmithKline, which has been chipping away at its supply chain in Romania with plans to close a plant there, will now unload its Romanian drug distribution…

Partnering